Your session is about to expire
← Back to Search
Dietary Supplement
Sodium and Fructose Diet for High Blood Pressure
N/A
Recruiting
Led By Ronald K McMillan, M.S
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
normal blood pressure
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 7 of diet intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial is studying how eating more salt and fructose affects blood pressure and inflammation in young healthy adults. The researchers aim to see if fructose makes people more sensitive to salt, leading to higher blood pressure and inflammation. Understanding these effects can help determine cardiovascular risk in people with normal blood pressure.
Who is the study for?
This trial is for young, healthy adults with normal blood pressure. It's open to all genders and ethnic groups. The study aims to understand how different diets affect blood pressure and inflammation.
What is being tested?
The study is testing three diets: one with recommended sodium levels and low fructose, another with high sodium but low fructose, and a third combining high sodium with high fructose to see their effects on blood pressure and inflammation.
What are the potential side effects?
While the trial involves dietary changes rather than medication, potential side effects may include fluctuations in blood pressure or inflammatory responses depending on individual sensitivity to sodium and fructose intake.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My blood pressure is within the normal range.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 7 of diet intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 7 of diet intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
24-hour Blood Pressure
Inflammatory cytokines
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Arm 3. High sodium and high fructose dietExperimental Treatment2 Interventions
7 day consumption of high fructose drink (200g) and recommended sodium (2300 mg)from whole food while consuming high sodium pills from pills (3400 mg)
Group II: Arm 2. High sodium and low fructose dietExperimental Treatment2 Interventions
7 day consumption of low fructose drink (20g) and recommended sodium (2300 mg) from whole food while consuming high sodium from pills (3400 mg)
Group III: Arm 1. Recommended sodium and low fructose dietExperimental Treatment2 Interventions
7 day consumption of low fructose drink (20g) and recommended sodium (2300mg) from whole food while consuming placebo from pills
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for inflammation often target dietary factors, such as reducing sodium and fructose intake. High sodium levels can increase blood pressure and promote inflammation by activating immune cells and increasing oxidative stress.
Fructose, particularly in high amounts, can lead to metabolic disturbances that exacerbate inflammation through increased production of uric acid and inflammatory cytokines. By managing these dietary components, patients can potentially reduce inflammation and its associated risks.
Understanding these mechanisms is crucial for patients as it highlights the importance of dietary choices in managing inflammation and improving overall health.
Find a Location
Who is running the clinical trial?
University of DelawareLead Sponsor
161 Previous Clinical Trials
25,602 Total Patients Enrolled
Ronald K McMillan, M.SPrincipal InvestigatorUniversity of Delaware
William B Farquhar, PhDPrincipal InvestigatorUniversity of Delaware
4 Previous Clinical Trials
226 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger